FDA Clearance Tracker · P200026
Abre Venous Self-expanding Stent System
Last checked: Nov 19, 2026Latest source record: Oct 21, 2020 (this decision)Source: openFDAMethods & limitations
Decided
Oct 21, 2020
Approved
Time to decision
177 days
Received Apr 27, 2020. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P200026
- Device name
- Abre Venous Self-expanding Stent System
- Applicant
- Medtronic Vascular, Inc.
- Applicant location
- Plymouth, MN
- Received
- Apr 27, 2020
- Decided
- Oct 21, 2020
- Decision
- Approved
- Supplements
- 20 in FDA's data for this PMA. See them on the FDA record
Device type
- Device type
- Stent, iliac vein (QAN)
- Device class
- Class III
- Specialty
- CardiologyInterventional Cardiology
FDA's approval statement
As written in FDA's record.
Approval for use in the iliofemoral veins for the treatment of symptomatic venous outflow obstruction.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code QAN. The earliest in FDA's data is P180037, decided Mar 13, 2019.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Medtronic Vascular, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K202800 · Decided Nov 18, 2020 · 56 days after receipt
Device type: Catheter, Angioplasty, Peripheral, Transluminal (LIT) · Cardiology
P190008 · Decided Nov 21, 2019 · 232 days after receipt
Device type: Drug-coated peripheral transluminal angioplasty catheter (PRC) · Cardiology
K182957 · Decided Nov 21, 2018 · 28 days after receipt
Device type: Endovascular Suturing System (OTD) · Cardiology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.